Electronic nicotine delivery systems: pragmatism or expectancy? – Authors’ reply

Sarah Jackson; Lion Shahab; Jamie Brown; Ann McNeill; Chris Bullen

doi:10.1016/S0140-6736(23)00281-7

Electronic nicotine delivery systems: pragmatism or expectancy? – Authors’ reply

Sarah Jackson, Lion Shahab, Jamie Brown, Ann McNeill, Chris Bullen

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1155-1156
Number of pages	2
Journal	The Lancet
Volume	401
Issue number	10383
DOIs	https://doi.org/10.1016/S0140-6736(23)00281-7
Publication status	Published - 8 Apr 2023

Access to Document

10.1016/S0140-6736(23)00281-7

Cite this

@article{3a89ef94245742058e1dc943f6f9515e,

title = "Electronic nicotine delivery systems: pragmatism or expectancy? – Authors{\textquoteright} reply",

author = "Sarah Jackson and Lion Shahab and Jamie Brown and Ann McNeill and Chris Bullen",

note = "Funding Information: All authors declare no financial links with tobacco companies, e-cigarette manufacturers, or their representatives. SJ receives salary support from Cancer Research UK and is a board member for the London Smoking Cessation Transformation Programme (a regional tobacco control programme). LS has received grants from Cancer Research UK and Yorkshire Cancer Research; has undertaken paid consultancy for the French Cancer Institute and Centre for Addiction and Mental Health, Toronto; is chair of the trial steering committee for the BabyBreathe trial; is an external advisory board member for the International Tobacco Control Policy Evaluation Project and Action on Smoking and Health; is co-chair of the UK E-cigarette Research Forum; and is Senior Editor for Addiction and Academic Editor for PLOS ONE. JB has funding for a programme grant from Cancer Research UK; has received unrestricted research funding from pharmaceutical companies (Pfizer and J&J) who manufacture smoking cessation medications; and receives royalties from Wiley for Theory of Addiction (second edition). AM has received funding from the Office for Health Improvement & Disparities/Public Health England for evidence updates on vaping in England published in 2019, 2021, and 2022. CB has received honoraria from the University of Malaya and AUT University for examining students and reviewing postgraduate courses; grants from the New Zealand Ministry of Health paid to his institution for research on the illicit trade in tobacco and New Zealand Smoking Cessation Guidelines; grants from the Health Research Council of New Zealand as a co-investigator on project grants for tobacco cessation research; is a subrecipient of a US National Institutes of Health grant from Wake Forest University, USA, for New Zealand-based surveys on low nicotine tobacco policy; is a member of the International Scientific Committee of the RESPIRE Study (University of Edinburgh), the Scientific Assessing Committee of the Cancer Society of New Zealand, and the Public Health Advisory Committee of the Health Research Council of New Zealand; and is the President, Oceania SRNT Chapter and President-Elect SRNT for the Society for Research on Nicotine and Tobacco.",

year = "2023",

month = apr,

day = "8",

doi = "10.1016/S0140-6736(23)00281-7",

language = "English",

volume = "401",

pages = "1155--1156",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier",

number = "10383",

}

TY - JOUR

T1 - Electronic nicotine delivery systems

T2 - pragmatism or expectancy? – Authors’ reply

AU - Jackson, Sarah

AU - Shahab, Lion

AU - Brown, Jamie

AU - McNeill, Ann

AU - Bullen, Chris

N1 - Funding Information: All authors declare no financial links with tobacco companies, e-cigarette manufacturers, or their representatives. SJ receives salary support from Cancer Research UK and is a board member for the London Smoking Cessation Transformation Programme (a regional tobacco control programme). LS has received grants from Cancer Research UK and Yorkshire Cancer Research; has undertaken paid consultancy for the French Cancer Institute and Centre for Addiction and Mental Health, Toronto; is chair of the trial steering committee for the BabyBreathe trial; is an external advisory board member for the International Tobacco Control Policy Evaluation Project and Action on Smoking and Health; is co-chair of the UK E-cigarette Research Forum; and is Senior Editor for Addiction and Academic Editor for PLOS ONE. JB has funding for a programme grant from Cancer Research UK; has received unrestricted research funding from pharmaceutical companies (Pfizer and J&J) who manufacture smoking cessation medications; and receives royalties from Wiley for Theory of Addiction (second edition). AM has received funding from the Office for Health Improvement & Disparities/Public Health England for evidence updates on vaping in England published in 2019, 2021, and 2022. CB has received honoraria from the University of Malaya and AUT University for examining students and reviewing postgraduate courses; grants from the New Zealand Ministry of Health paid to his institution for research on the illicit trade in tobacco and New Zealand Smoking Cessation Guidelines; grants from the Health Research Council of New Zealand as a co-investigator on project grants for tobacco cessation research; is a subrecipient of a US National Institutes of Health grant from Wake Forest University, USA, for New Zealand-based surveys on low nicotine tobacco policy; is a member of the International Scientific Committee of the RESPIRE Study (University of Edinburgh), the Scientific Assessing Committee of the Cancer Society of New Zealand, and the Public Health Advisory Committee of the Health Research Council of New Zealand; and is the President, Oceania SRNT Chapter and President-Elect SRNT for the Society for Research on Nicotine and Tobacco.

PY - 2023/4/8

Y1 - 2023/4/8

UR - http://www.scopus.com/inward/record.url?scp=85151505803&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(23)00281-7

DO - 10.1016/S0140-6736(23)00281-7

M3 - Letter

C2 - 37030884

AN - SCOPUS:85151505803

SN - 0140-6736

VL - 401

SP - 1155

EP - 1156

JO - The Lancet

JF - The Lancet

IS - 10383

ER -

Electronic nicotine delivery systems: pragmatism or expectancy? – Authors’ reply

Access to Document

Other files and links

Cite this